Johnson & Johnson (JNJ): are the analysts right?

Johnson & Johnson · Health Care · ref. ETF XLV · 77 calls · price $267.24
What the company does: Johnson & Johnson fabrique et vend des produits pharmaceutiques, dispositifs médicaux et consommables de santé.
📈 1-year price
$267.24+71.5% over range
Jul 8, 25low $155.17 · high $267.24Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
56% recommend buying · 16 analysts
⚠️ The stock trades above the median target: it has beaten expectations. The “Buy” reflects conviction on the company, but the remaining quantified upside is low/negative.

🎯 Analyst price target on JNJ

High target · 2 analysts$280+4.8%
Median target · 16 analysts$255-4.6%
Low target · 1 analyst$208-22.2%
Current price$267.24

🗳️ The analyst consensus

Analyst breakdown · 16 (6 months)
Strong Buy0%
Buy56%
Hold44%
Sell0%
Strong Sell0%

💰 Johnson & Johnson dividend

2.06%annual yield
📈 Steady dividend23 yrs of consecutive dividend increases
That's ~$5.24 per share per year.

✅ Historical analyst reliability on JNJ

Most reliable analysts on JNJ (% profitable · 365j · ≥2 calls)
RBC Capital 100% +30.5% 12
Cantor Fitzgerald 100% +8.7% 12

📊 What $1,000 invested in Johnson & Johnson would be worth

In short — $1,000 invested in Johnson & Johnson 10 years ago would be worth $2,472 today, i.e. +9%/yr on average. Best year: 2025 (+43%), worst: 2023 (-11%). Price performance, excluding dividends.

If I'd invested $1,000 in Johnson & Johnson

InvestmentWorth todayGain
1 years ago$1,756+76%
3 years ago$1,438+44%
5 years ago$1,614+61%
10 years ago$2,472+147%
since inception (1985)$96,750+9575%

Return by year (Johnson & Johnson)

YearReturn$1,000 invested at year start
2026 (YTD)+23%$1,227 (+23%)
2025+43%$1,756 (+76%)
2024-8%$1,620 (+62%)
2023-11%$1,438 (+44%)
2022+3%$1,485 (+48%)
2021+9%$1,614 (+61%)
2020+8%$1,741 (+74%)
2019+13%$1,968 (+97%)
2018-8%$1,818 (+82%)
2017+21%$2,204 (+120%)
2016+12%$2,472 (+147%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance💰 Dividend
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on JNJ

Guggenheim
Jun 26, 26
▲ Buy · 🎯$270
Price at call : $258.51 — upside +4%
Today : $267.24 — upside +1%
🎯 on JNJ : no call matured yet · 📊 on Health : 52.8% · +3.9% (89 calls)
in progress (365j)
matures : Jun 26, 27
▲ Outperform · 🎯$265
Price at call : $230.8 — upside +15%
Today : $267.24 — upside -1%
🎯 on JNJ : 100% (1 call matured) · 📊 on Health : 57.1% · +6.2% (35 calls)
in progress (365j)
matures : May 13, 27
Barclays
Apr 15, 26
■ Equal-Weight neutral · not a buy · 🎯$255
Price at call : $234.54 — gap to target +9%
Today : $267.24 — gap to target -5%
🎯 on JNJ : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Apr 15, 27
Stifel
Apr 15, 26
■ Hold neutral · not a buy · 🎯$250
Price at call : $234.54 — gap to target +7%
Today : $267.24 — gap to target -6%
🎯 on JNJ : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Apr 15, 27
Wells Fargo
Apr 15, 26
▲ Overweight · 🎯$263
Price at call : $234.54 — upside +12%
Today : $267.24 — upside -2%
🎯 on JNJ : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Apr 15, 27
▲ Overweight · 🎯$267
Price at call : $237.96 — upside +12%
Today : $267.24 — upside -0%
🎯 on JNJ : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Apr 10, 27
RBC Capital
Mar 30, 26
▲ Outperform · 🎯$255
Price at call : $244.44 — upside +4%
Today : $267.24 — upside -5%
🎯 on JNJ : 100% (12 calls matureds) · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Mar 30, 27
Barclays
Mar 19, 26
■ Equal-Weight neutral · not a buy · 🎯$234
Price at call : $235.37 — gap to target -1%
Today : $267.24 — gap to target -12%
🎯 on JNJ : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Mar 19, 27
HSBC
Mar 17, 26
▲ Buy · 🎯$280
Price at call : $237.28 — upside +18%
Today : $267.24 — upside +5%
🎯 on JNJ : no call matured yet · 📊 on Health : 53.6% · +1.4% (28 calls)
in progress (365j)
matures : Mar 17, 27
Citigroup
Mar 11, 26
▲ Buy · 🎯$274
Price at call : $242.04 — upside +13%
Today : $267.24 — upside +3%
🎯 on JNJ : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Mar 11, 27
JP Morgan
Mar 5, 26
■ Neutral neutral · not a buy · 🎯$250
Price at call : $240.4 — gap to target +4%
Today : $267.24 — gap to target -6%
🎯 on JNJ : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Mar 5, 27
RBC Capital
Feb 3, 26
▲ Outperform · 🎯$255
Price at call : $234.47 — upside +9%
Today : $267.24 — upside -5%
🎯 on JNJ : 100% (12 calls matureds) · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Feb 3, 27
▲ Overweight · 🎯$262
Price at call : $227.72 — upside +15%
Today : $267.24 — upside -2%
🎯 on JNJ : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Jan 28, 27
■ Hold neutral · not a buy · 🎯$220
Price at call : $227.72 — gap to target -3%
Today : $267.24 — gap to target -18%
🎯 on JNJ : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Jan 27, 27
Freedom Broker
Jan 27, 26
■ Hold neutral · not a buy · 🎯$220
Price at call : $224.44 — gap to target -2%
Today : $267.24 — gap to target -18%
🎯 on JNJ : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Jan 27, 27
Guggenheim
Jan 23, 26
▲ Buy · 🎯$240
Price at call : $220.14 — upside +9%
Today : $267.24 — upside -10%
🎯 on JNJ : no call matured yet · 📊 on Health : 52.8% · +3.9% (89 calls)
in progress (365j)
matures : Jan 23, 27
Citigroup
Jan 22, 26
▲ Buy · 🎯$250
Price at call : $220.14 — upside +14%
Today : $267.24 — upside -6%
🎯 on JNJ : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Jan 22, 27
■ Neutral neutral · not a buy · 🎯$221
Price at call : $220.14 — gap to target +0%
Today : $267.24 — gap to target -17%
🎯 on JNJ : no call matured yet · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Jan 22, 27
TD Cowen
Jan 22, 26
▲ Buy · 🎯$250
Price at call : $220.14 — upside +14%
Today : $267.24 — upside -6%
🎯 on JNJ : no call matured yet · 📊 on Health : 48.4% · +0.8% (95 calls)
in progress (365j)
matures : Jan 22, 27
■ Equal-Weight neutral · not a buy · 🎯$200
Price at call : $220.14 — gap to target -9%
Today : $267.24 — gap to target -25%
🎯 on JNJ : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Jan 22, 27
Wells Fargo
Jan 22, 26
▲ Overweight · 🎯$240
Price at call : $220.14 — upside +9%
Today : $267.24 — upside -10%
🎯 on JNJ : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Jan 22, 27
Scotiabank
Jan 22, 26
▲ Sector Outperform · 🎯$265
Price at call : $220.14 — upside +20%
Today : $267.24 — upside -1%
🎯 on JNJ : no call matured yet · 📊 on Health : 16.7% · -12.6% (6 calls)
in progress (365j)
matures : Jan 22, 27
Stifel
Jan 22, 26
■ Hold neutral · not a buy · 🎯$220
Price at call : $218.49 — gap to target +1%
Today : $267.24 — gap to target -18%
🎯 on JNJ : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Jan 22, 27
Bernstein
Jan 9, 26
■ Market Perform neutral · not a buy · 🎯$208
Price at call : $209.72 — gap to target -1%
Today : $267.24 — gap to target -22%
🎯 on JNJ : no call matured yet · 📊 on Health : 55.6% · +5.7% (63 calls)
in progress (365j)
matures : Jan 9, 27
Barclays
Dec 30, 25
■ Equal-Weight neutral · not a buy · 🎯$217
Price at call : $206.91 — gap to target +5%
Today : $267.24 — gap to target -19%
🎯 on JNJ : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Dec 30, 26
Goldman Sachs
Dec 19, 25
▲ Buy · 🎯$240
Price at call : $207.32 — upside +16%
Today : $267.24 — upside -10%
🎯 on JNJ : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Dec 19, 26
■ Neutral neutral · not a buy · 🎯$220
Price at call : $214.17 — gap to target +3%
Today : $267.24 — gap to target -18%
🎯 on JNJ : no call matured yet · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Dec 15, 26
■ Equal-Weight neutral · not a buy · 🎯$197
Price at call : $214.17 — gap to target -8%
Today : $267.24 — gap to target -26%
🎯 on JNJ : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Dec 12, 26
Citigroup
Dec 11, 25
▲ Buy · 🎯$232
Price at call : $211.58 — upside +10%
Today : $267.24 — upside -13%
🎯 on JNJ : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Dec 11, 26
RBC Capital
Dec 11, 25
▲ Outperform · 🎯$230
Price at call : $211.58 — upside +9%
Today : $267.24 — upside -14%
🎯 on JNJ : 100% (12 calls matureds) · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Dec 11, 26
Guggenheim
Dec 5, 25
▲ Buy · 🎯$227
Price at call : $201.93 — upside +12%
Today : $267.24 — upside -15%
🎯 on JNJ : no call matured yet · 📊 on Health : 52.8% · +3.9% (89 calls)
in progress (365j)
matures : Dec 5, 26
Barclays
Dec 2, 25
■ Equal-Weight neutral · not a buy · 🎯$197
Price at call : $205.42 — gap to target -4%
Today : $267.24 — gap to target -26%
🎯 on JNJ : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Dec 2, 26
Freedom Broker
Oct 22, 25
■ Hold neutral · not a buy · 🎯$190
Price at call : $192.47 — gap to target -1%
Today : $267.24 — gap to target -29%
🎯 on JNJ : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Oct 22, 26
Citigroup
Oct 15, 25
▲ Buy · 🎯$215
Price at call : $192.12 — upside +12%
Today : $267.24 — upside -20%
🎯 on JNJ : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Oct 15, 26
Stifel
Oct 15, 25
■ Hold neutral · not a buy · 🎯$190
Price at call : $192.12 — gap to target -1%
Today : $267.24 — gap to target -29%
🎯 on JNJ : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Oct 15, 26
Raymond James
Oct 15, 25
▲ Outperform · 🎯$209
Price at call : $192.12 — upside +9%
Today : $267.24 — upside -22%
🎯 on JNJ : no call matured yet · 📊 on Health : 46.8% · +2.0% (395 calls)
in progress (365j)
matures : Oct 15, 26
■ Equal-Weight neutral · not a buy · 🎯$190
Price at call : $191.17 — gap to target -1%
Today : $267.24 — gap to target -29%
🎯 on JNJ : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Oct 15, 26
■ Neutral neutral · not a buy · 🎯$204
Price at call : $191.17 — gap to target +7%
Today : $267.24 — gap to target -24%
🎯 on JNJ : no call matured yet · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Oct 15, 26
UBS
Oct 14, 25
▲ Buy · 🎯$214
Price at call : $191.17 — upside +12%
Today : $267.24 — upside -20%
🎯 on JNJ : no call matured yet · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Oct 14, 26
■ Equal-Weight neutral · not a buy · 🎯$178
Price at call : $190.9 — gap to target -7%
Today : $267.24 — gap to target -33%
🎯 on JNJ : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Oct 10, 26
▲ Buy · 🎯$212
Price at call : $190.72 — upside +11%
Today : $267.24 — upside -21%
🎯 on JNJ : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Oct 9, 26
Citigroup
Oct 7, 25
▲ Buy · 🎯$213
Price at call : $189.69 — upside +12%
Today : $267.24 — upside -20%
🎯 on JNJ : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Oct 7, 26
Bernstein
Oct 6, 25
■ Market Perform neutral · not a buy · 🎯$193
Price at call : $188.16 — gap to target +3%
Today : $267.24 — gap to target -28%
🎯 on JNJ : no call matured yet · 📊 on Health : 55.6% · +5.7% (63 calls)
in progress (365j)
matures : Oct 6, 26
■ Neutral neutral · not a buy · 🎯$198
Price at call : $188.64 — gap to target +5%
Today : $267.24 — gap to target -26%
🎯 on JNJ : no call matured yet · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Oct 3, 26
Wells Fargo
Oct 3, 25
▲ Overweight · 🎯$212
Price at call : $188.64 — upside +12%
Today : $267.24 — upside -21%
🎯 on JNJ : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Oct 3, 26
Guggenheim
Sep 23, 25
▲ Buy · 🎯$206
Price at call : $176.58 — upside +17%
Today : $267.24 — upside -23%
🎯 on JNJ : no call matured yet · 📊 on Health : 52.8% · +3.9% (89 calls)
in progress (365j)
matures : Sep 23, 26
JP Morgan
Sep 16, 25
■ Neutral neutral · not a buy · 🎯$200
Price at call : $176.46 — gap to target +13%
Today : $267.24 — gap to target -25%
🎯 on JNJ : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Sep 16, 26
Citigroup
Aug 21, 25
▲ Buy · 🎯$200
Price at call : $179.29 — upside +12%
Today : $267.24 — upside -25%
🎯 on JNJ : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Aug 21, 26
Barclays
Jul 17, 25
■ Equal-Weight neutral · not a buy · 🎯$176
Price at call : $163.7 — gap to target +8%
Today : $267.24 — gap to target -34%
🎯 on JNJ : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Jul 17, 26
RBC Capital
Jul 17, 25
▲ Outperform · 🎯$185
Price at call : $163.7 — upside +13%
Today : $267.24 — upside -31%
🎯 on JNJ : 100% (12 calls matureds) · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Jul 17, 26
RBC Capital
Jun 5, 25
▲ Outperform · 🎯$181
Price at call : $155.03 — upside +17%
Today : $267.24 — upside -32%
Expected +17% · Actual +50% · Reason (≥ +15%) : ✓ Yes
🎯 on JNJ : 100% (12 calls matureds) · 📊 on Health : 43% · -1.9% (381 calls)
+49.8%
stock +50% · XLV +14%
■ Market Perform neutral · not a buy · 🎯$153
Price at call : $146.36 — gap to target +5%
Today : $267.24 — gap to target -43%
🎯 on JNJ : 100% (1 call matured) · 📊 on Health : 57.1% · +6.2% (35 calls)
in progress (365j)
matures : May 13, 26
RBC Capital
Apr 16, 25
▲ Outperform · 🎯$181
Price at call : $157.47 — upside +15%
Today : $267.24 — upside -32%
Expected +15% · Actual +49% · Reason (≥ +15%) : ✓ Yes
🎯 on JNJ : 100% (12 calls matureds) · 📊 on Health : 43% · -1.9% (381 calls)
+48.7%
stock +49% · XLV +10%
RBC Capital
Apr 3, 25
▲ Outperform · 🎯$181
Price at call : $153.24 — upside +18%
Today : $267.24 — upside -32%
Expected +18% · Actual +57% · Reason (≥ +15%) : ✓ Yes
🎯 on JNJ : 100% (12 calls matureds) · 📊 on Health : 43% · -1.9% (381 calls)
+57.3%
stock +57% · XLV +8%
RBC Capital
Apr 2, 25
▲ Outperform · 🎯$181
Price at call : $159.82 — upside +13%
Today : $267.24 — upside -32%
Expected +13% · Actual +51% · Reason (≥ +15%) : ✓ Yes
🎯 on JNJ : 100% (12 calls matureds) · 📊 on Health : 43% · -1.9% (381 calls)
+50.8%
stock +51% · XLV +2%
RBC Capital
Feb 19, 25
▲ Outperform · 🎯$181
Price at call : $159.68 — upside +13%
Today : $267.24 — upside -32%
Expected +13% · Actual +52% · Reason (≥ +15%) : ✓ Yes
🎯 on JNJ : 100% (12 calls matureds) · 📊 on Health : 43% · -1.9% (381 calls)
+51.9%
stock +52% · XLV +7%
RBC Capital
Jan 23, 25
▲ Outperform · 🎯$181
Price at call : $146.82 — upside +23%
Today : $267.24 — upside -32%
Expected +23% · Actual +51% · Reason (≥ +15%) : ✓ Yes
🎯 on JNJ : 100% (12 calls matureds) · 📊 on Health : 43% · -1.9% (381 calls)
+50.9%
stock +51% · XLV +10%
▲ Outperform · 🎯$169
Price at call : $146.82 — upside +15%
Today : $267.24 — upside -37%
Expected +15% · Actual +51% · Reason (≥ +15%) : ✓ Yes
🎯 on JNJ : 100% (1 call matured) · 📊 on Health : 57.1% · +6.2% (35 calls)
+50.9%
stock +51% · XLV +10%
▲ Overweight · 🎯$215
Price at call : $164.47 — upside +31%
Today : $267.24 — upside -20%
Expected +31% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on JNJ : 100% (12 calls matureds) · 📊 on Health : 37.9% · -3.5% (335 calls)
+17.5%
stock +17% · XLV -6%
RBC Capital
Oct 16, 24
▲ Outperform · 🎯$181
Price at call : $164.28 — upside +10%
Today : $267.24 — upside -32%
Expected +10% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on JNJ : 100% (12 calls matureds) · 📊 on Health : 43% · -1.9% (381 calls)
+17.0%
stock +17% · XLV -7%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)